Corruption in the Pharmaceutical Trade BAYER AG As an opener to this article that describes very directly what the corporate world of pharmaceuticals is about, I would like to quote Marijn Dekkers, CEO of Bayer AG, December 3, 2013 – “We did not develop this medicine for Indians. We developed it for Western patients who can afford it.” The original Businessweek article has been removed from the internet, including its internet cache and the video that was on ft-live.com . https://www.keionline.org/node/1924 , http://www.dailymail.co.uk/news/article-2545360/Pharmaceutical-chief-tries-stop-India-replicating-cancer-treatment.html Bayer AG can trace its roots back to August 1863 with the creation of “Friedr.Bayer et comp”, a partnership between businessman Friederich Bayer, and Johann Friederich Weskott, a master dyer. This company would specialize in the manufacture of synthetic dyes and was based in Barmen, now part of Wuppertal in Germany. The company grew quickly, exporting dyes a